Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review

By A. Plint, David Moher, A. Morrison, K. F. Schulz, Douglas G. Altman, C. Hill, I. Gaboury. Medical Journal of Australia, 2006

864 citations recorded by the source corpus.

Subfields: General Health Professions, Statistics and Probability

View Paper: https://www.semanticscholar.org/paper/44fe6e14438a0c0fcb4bf1397d3753f1dc58a5da

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In General Health Professions

1. David Moher
2. Douglas G. Altman
3. K. F. Schulz
4. Joshua Carp
5. Larissa Shamseer
6. P. Gøtzsche
7. Mike Clarke
8. E. von Elm

In Statistics and Probability

1. David Moher
2. Douglas G. Altman
3. K. F. Schulz
4. John P. A. Ioannidis
5. Matthias Egger
6. P. Gøtzsche
7. Stuart J. Pocock
8. J. Tetzlaff

Citations in the corpus

• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007, positive): “Many medical journals supported this initiative (13), which has helped to improve the quality of reports of randomized trials (14, 15).”
• CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. (2012, methodology): “The first version of the CONSORT statement, from 1996, seems to have led to improvement in the quality of reporting of RCTs in the journals that have adopted it [50 e 54].”
• Reporting guidelines for Human Microbiome Research: the STORMS checklist (2021, methodology): “Editorial adoption of the CONSORT (Consolidated Standards of Reporting Trials) guidelines, for example, has been associated with an increase in the quality of trial reporting 5,6 .”
• CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010, background): “[50-54].”
• Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. (2008, methodology): “Use of this evidence-based guideline is associated with improved quality of reporting in RCTs (3).”
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007, positive): “Many medical journals supported this initiative [13], which has helped to improve the quality of reports of randomised trials [14,15].”
• MIFlowCyt: The Minimum Information about a Flow Cytometry Experiment (2008, background): “DISCUSSION The importance of minimal data reporting standards is illustrated by both community-driven standards such as MIAME (13), MIRIAM (14), MISFISHIE (15), and the CONSORT checklist (16), and cross-community efforts including MIBBI (5), FuGE (6), and OBI (7).”
• The secret lives of experiments: Methods reporting in the fMRI literature (2012, positive): “Articles published in journals that endorse the CONSORT recommendations report key methodological decisions more thoroughly than articles published in the same journals before CONSORT was adopted, and more thoroughly than articles published concurrently in non-CONSORT journals (Plint et al., 2006).”
• Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use (2016, methodology): “Consolidated Standards of Reporting Trials (CONSORT) statement, which has led to improved reporting of randomized controlled trials [16, 17].”
• CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials (2010, neutral): “While those statements improved the reporting quality for some randomised controlled trials [9,10], many trial reports still remain inadequate [2].”
• ORIGINAL ARTICLES The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies (2008, positive): “Many medical journals supported this initiative [13], which has helped to improve the quality of reports of randomized trials [ 14 ,15].”
• Korean translation of the CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials (2014, neutral): “이러한 지지는 정당한 것으로 생각되는 데, 저자와 학술지에 의해 CONSORT가 사용될 때 보고 내용의 질 이 향상되는 것으로 여겨지기 때문이다 [9].”
• What is missing from descriptions of treatment in trials and reviews? (2008, background): “Have you ever read a trial or review and wondered exactly how to carry out treatments such as a “behavioural intervention,” “salt reduction,” or “exercise programme”? Although CONSORT and related initiatives have focused on the assessment of validity and presentation of results,”